531 related articles for article (PubMed ID: 19590502)
1. Variation in the safety of induced pluripotent stem cell lines.
Miura K; Okada Y; Aoi T; Okada A; Takahashi K; Okita K; Nakagawa M; Koyanagi M; Tanabe K; Ohnuki M; Ogawa D; Ikeda E; Okano H; Yamanaka S
Nat Biotechnol; 2009 Aug; 27(8):743-5. PubMed ID: 19590502
[TBL] [Abstract][Full Text] [Related]
2. Fates of murine pluripotent stem cell-derived neural progenitors following transplantation into mouse cochleae.
Nishimura K; Nakagawa T; Sakamoto T; Ito J
Cell Transplant; 2012; 21(4):763-71. PubMed ID: 22305181
[TBL] [Abstract][Full Text] [Related]
3. Strategies toward CNS-regeneration using induced pluripotent stem cells.
Okano H
Genome Inform; 2009 Oct; 23(1):217-20. PubMed ID: 20180278
[TBL] [Abstract][Full Text] [Related]
4. Establishment of induced pluripotent stem cells from human neonatal tissues.
Fujioka T; Shimizu N; Yoshino K; Miyoshi H; Nakamura Y
Hum Cell; 2010 Aug; 23(3):113-8. PubMed ID: 20973836
[TBL] [Abstract][Full Text] [Related]
5. STB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation.
Choi SW; Shin TH; Uddin MH; Shin JH; Kang TW; Lee BC; Kim HS; Seo Y; Shams S; Jung YK; Kang KS
Oncotarget; 2016 Jan; 7(3):2684-95. PubMed ID: 26646796
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of human induced pluripotent stem cells.
Ohnuki M; Takahashi K; Yamanaka S
Curr Protoc Stem Cell Biol; 2009 Jun; Chapter 4():Unit 4A.2. PubMed ID: 19536759
[TBL] [Abstract][Full Text] [Related]
7. The development of pluripotent stem cells.
Gokhale PJ; Andrews PW
Curr Opin Genet Dev; 2012 Oct; 22(5):403-8. PubMed ID: 22868175
[TBL] [Abstract][Full Text] [Related]
8. Germline-competent mouse-induced pluripotent stem cell lines generated on human fibroblasts without exogenous leukemia inhibitory factor.
Li C; Yu H; Ma Y; Shi G; Jiang J; Gu J; Yang Y; Jin S; Wei Z; Jiang H; Li J; Jin Y
PLoS One; 2009 Aug; 4(8):e6724. PubMed ID: 19696928
[TBL] [Abstract][Full Text] [Related]
9. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of mouse induced pluripotent stem cells into neurons using conditioned medium of dorsal root ganglia.
Kitazawa A; Shimizu N
N Biotechnol; 2011 Jul; 28(4):326-33. PubMed ID: 21477670
[TBL] [Abstract][Full Text] [Related]
11. Teratoma generation in the testis capsule.
Peterson SE; Tran HT; Garitaonandia I; Han S; Nickey KS; Leonardo T; Laurent LC; Loring JF
J Vis Exp; 2011 Nov; (57):e3177. PubMed ID: 22158256
[TBL] [Abstract][Full Text] [Related]
12. Adult mice generated from induced pluripotent stem cells.
Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Gifford W; Martin G; Kupriyanov S; Baldwin KK
Nature; 2009 Sep; 461(7260):91-4. PubMed ID: 19672243
[TBL] [Abstract][Full Text] [Related]
13. Comparison of American mink embryonic stem and induced pluripotent stem cell transcriptomes.
Menzorov AG; Matveeva NM; Markakis MN; Fishman VS; Christensen K; Khabarova AA; Pristyazhnyuk IE; Kizilova EA; Cirera S; Anistoroaei R; Serov OL
BMC Genomics; 2015; 16 Suppl 13(Suppl 13):S6. PubMed ID: 26694224
[TBL] [Abstract][Full Text] [Related]
14. [Differentiation of pluripotent embryonic stem cells in peritoneal cavity of irradiated mice].
Gordeeva OF; Manuilova ES; Paiushina OV; Nikonova TM; Grivennikov IA; Khrushchev NG
Izv Akad Nauk Ser Biol; 2003; (3):371-4. PubMed ID: 12816072
[TBL] [Abstract][Full Text] [Related]
15. iPS cells produce viable mice through tetraploid complementation.
Zhao XY; Li W; Lv Z; Liu L; Tong M; Hai T; Hao J; Guo CL; Ma QW; Wang L; Zeng F; Zhou Q
Nature; 2009 Sep; 461(7260):86-90. PubMed ID: 19672241
[TBL] [Abstract][Full Text] [Related]
16. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
Kamada M; Mitsui Y; Matsuo T; Takahashi T
Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
[TBL] [Abstract][Full Text] [Related]
17. Teratoma formation: a tool for monitoring pluripotency in stem cell research.
Nelakanti RV; Kooreman NG; Wu JC
Curr Protoc Stem Cell Biol; 2015 Feb; 32():4A.8.1-4A.8.17. PubMed ID: 25640819
[TBL] [Abstract][Full Text] [Related]
18. Murine embryonic stem cell derivation, in vitro pluripotency characterization, and in vivo teratoma formation.
Chou YF; Yabuuchi A
Curr Protoc Toxicol; 2011 Nov; Chapter 2():Unit2.22. PubMed ID: 22058054
[TBL] [Abstract][Full Text] [Related]
19. Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.
Dressel R; Guan K; Nolte J; Elsner L; Monecke S; Nayernia K; Hasenfuss G; Engel W
Biol Direct; 2009 Aug; 4():31. PubMed ID: 19715575
[TBL] [Abstract][Full Text] [Related]
20. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
